Innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases.
Medibiofarma has raised €1.2M across 1 funding round from 5 investors, most recently a round in Mar 2022. Based in Navarre, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-15 | Other |
| €1.2M |
| CDTI,ENISA,Fitalent,Inveready,Sodena |
| View deal → |
